financetom
Business
financetom
/
Business
/
Don’t expect much impact on ad revenues if lockdowns restricted to Q1FY22: Zee Entertainment
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Don’t expect much impact on ad revenues if lockdowns restricted to Q1FY22: Zee Entertainment
May 21, 2021 3:28 AM

Zee Entertainment Enterprise Ltd on Thursday reported a consolidated net profit of Rs 272.36 crore in Q4 as against a loss of Rs 765.82 crore in the same quarter last year. The profit was on the back of strong ad revenues for the quarter under review.

In an interview with CNBC-TV18, Rohit Gupta, CFO, of the company said that although the company saw double digit growth in ad revenues in Q4FY21, they will be impacted in Q1FY22 due to second wave of COVID and the consequent lockdowns. HE added that if lockdowns are restricted to the first quarter, the impact will be less.

“Due to increase in COVID cases and consequent lockdown across the country, advertisers have started pulling back spends. At present looks like Q1FY22 would be impacted, but it will not be as impacted as it was in Q1FY21 where we had seen revenue falling by two thirds. We are optimistic that a good start of this loss would be offset if lockdowns do not extend beyond Q1FY22,” he said in an interview to CNBC-TV18.

Meanwhile, the broadcast subscription revenue remained flat in Q4FY21 for the company. However, Gupta said that as there is a freeze on pricing of channels the company would not be able to substantially grow subscription revenues for the broadcast business.

The firm is also expecting to see a drop in margins from the historical levels of 30 percent. “We would be increasing our investments across our businesses and as we do increase our investments, we would see a transient dip in EBITDA margins. We have done a 5-year plan and we believe we will see a drop in margin for around 2 years. During this phase the margin would be around 25 percent plus and once this phase is over, we would be back to margins of 30 percent plus,” he said.

He also said that the reduction in Zee5's annual fee will have some impact on revenue in near term. However, he expects that it will help in getting more B2C customers.

Watch the video for more.

(Edited by : Pranati Deva)

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Once a beacon of stability, Vietnam to name third president in a year
Once a beacon of stability, Vietnam to name third president in a year
Mar 22, 2024
HANOI, March 22 (Reuters) - Communist-ruled Vietnam is seeking its third president in little more than a year after the resignation of Vo Van Thuong, who was only elected last year after the sudden dismissal of his predecessor. With accumulated foreign direct investment higher than its gross domestic product, Vietnam's stability is crucial to multinationals with large operations in the...
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Cathie Wood's ARK Invest scoops up nearly 10,000 Reddit shares in debut
Mar 22, 2024
(Reuters) - Popular investor Cathie Wood's ARK Invest bought nearly 10,000 shares of Reddit ( RDDT ) in the social media platform's strong market debut on Thursday, an email from the asset manager showed. A total of 9,982 shares of the loss-making company was added to ARK Next Generation Internet ETF ( ARKW ) and ARK Fintech Innovation ETF (...
Japan's union group Rengo announces biggest wage hikes on record
Japan's union group Rengo announces biggest wage hikes on record
Mar 22, 2024
TOKYO (Reuters) -Japanese firms have agreed to raise pay by 5.25% this year, the biggest rise under comparable data since 2013, the country's largest union group Rengo confirmed on Friday. The results of the closely-watched wage negotiations are announced in several stages, in which the blue-chip firms are first to wrap up their talks in mid-March. The second announcement on...
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Hutchmed Begins Registration Stage for Phase 2/3 Trial of Investigational Autoimmune Disorder Drug
Mar 22, 2024
05:04 AM EDT, 03/22/2024 (MT Newswires) -- Hutchmed ( HCM ) said late Thursday it has started the registration stage for a phase 2/3 clinical trial of investigational drug sovleplenib for adult patients with warm antibody autoimmune hemolytic anemia in China. The move follows positive data from the proof-of-concept phase 2 stage of the trial and a consultation with the...
Copyright 2023-2026 - www.financetom.com All Rights Reserved